Position in ZTS
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$2,563,383
-$145,647 QoQ
Shares Held
21,685
+0.7% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Callan Family Office, LLC holds $21,578,279 across 11 Drug Manufacturers - Specialty & Generic names. ZTS ranks #4 (11.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HLN |
Haleon plc
|
734,570 | $7,353,045 | |
| 2 | ELAN |
Elanco Animal Health Inc
|
164,316 | $3,932,081 | |
| 3 | TAK |
Takeda Pharmaceutical Co Ltd
|
162,957 | $3,017,963 | |
| 4 | ZTS |
Zoetis Inc.
This page
|
21,685 | $2,563,383 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
63,254 | $1,905,210 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
2,083 | $1,235,177 | |
| 7 | PBH |
Prestige Consumer Healthcare Inc.
|
8,666 | $513,633 | |
| 8 | HIMS |
Hims & Hers Health, Inc.
|
18,020 | $374,095 |
All Filings in ZTS
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,563,383 | 21,685 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $2,709,030 | 21,531 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $1,941,812 | 13,271 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $2,451,066 | 15,717 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $1,077,963 | 6,547 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $1,126,986 | 6,917 | Shares | Sole | 2025-02-07 | |
| No filing history on record for this holder in this stock. | ||||||